These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32604059)

  • 1. A novel technique of arterial blood flow modification in intra-arterial chemoradiotherapy of maxillary sinus squamous cell carcinoma.
    Kanno C; Masubuchi T; Fushimi C; Kitani Y; Niwa K; Takeishi E; Kaneko T; Yamazaki M; Hasegawa H; Kamata SE; Miura K; Tada Y
    Oral Oncol; 2020 Jun; 109():104873. PubMed ID: 32604059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer.
    Mitsudo K; Shigetomi T; Fujimoto Y; Nishiguchi H; Yamamoto N; Furue H; Ueda M; Itoh Y; Fuwa N; Tohnai I
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1428-35. PubMed ID: 20605340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary results of proton beam therapy combined with weekly cisplatin intra-arterial infusion via a superficial temporal artery for treatment of maxillary sinus carcinoma.
    Nakamura T; Azami Y; Ono T; Yamaguchi H; Hayashi Y; Suzuki M; Hatayama Y; Tsukiyama I; Hareyama M; Kikuchi Y; Takayama K; Fuwa N
    Jpn J Clin Oncol; 2016 Jan; 46(1):46-50. PubMed ID: 26538461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant Superselective Intra-Arterial Cisplatin Chemoradiotherapy Combined With Surgery in Patients With T4 Squamous Cell Carcinoma of the Maxillary Sinus.
    Ikeda M; Suzuki M; Matsuzuka T; Ishii S; Sato H; Murono S
    J Oral Maxillofac Surg; 2022 Aug; 80(8):1445-1450. PubMed ID: 35636468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of intra-arterial docetaxel and nedaplatin infusion concomitant with radiotherapy for T4 maxillary sinus squamous cell carcinoma.
    Heianna J; Makino W; Hirakawa H; Yamashita Y; Tomita H; Murayama S
    Int J Oral Maxillofac Surg; 2022 Sep; 51(9):1123-1130. PubMed ID: 34955352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical T staging is superior to fluorodeoxyglucose positron emission tomography for predicting local outcomes after intra-arterial infusion chemoradiotherapy for maxillary sinus squamous cell carcinoma.
    Doi H; Fujiwara M; Kitajima K; Tanooka M; Terada T; Noguchi K; Ishikura R; Kamikonya N; Yamakado K
    Nagoya J Med Sci; 2018 Nov; 80(4):541-550. PubMed ID: 30587868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-Finding and Efficacy Confirmation Trial of the Superselective Intra-arterial Infusion of Cisplatin and Concomitant Radiation Therapy for Locally Advanced Maxillary Sinus Cancer (JCOG1212): Results of the Efficacy Confirmation Phase in Patients with T4aN0M0.
    Homma A; Mikami M; Matsuura K; Onimaru R; Yoshida D; Shinomiya H; Ohkoshi A; Hayashi R; Saito Y; Tachibana H; Shiga K; Ueda T; Uemura H; Nakamura K; Fukuda H;
    Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1271-1281. PubMed ID: 38008195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging predictor of ophthalmic involvement in maxillary sinus cancer during super selective intra-arterial cisplatin infusion and concomitant radiotherapy (RADPLAT).
    Ashida H; Igarashi T; Nozawa Y; Munetomo Y; Higuchi T; Yamauchi H; Baba A; Abe Y; Shimura E; Kessoku H; Nishiya Y; Kojima H; Ojiri H
    Head Face Med; 2021 Aug; 17(1):34. PubMed ID: 34399796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage operations for patients with persistent or recurrent cancer of the maxillary sinus after superselective intra-arterial infusion of cisplatin with concurrent radiotherapy.
    Sakashita T; Homma A; Hatakeyama H; Kano S; Mizumachi T; Furusawa J; Yoshida D; Fujima N; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Suzuki F; Fukuda S
    Br J Oral Maxillofac Surg; 2014 Apr; 52(4):323-8. PubMed ID: 24582012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-arterial chemoradiation therapy with weekly low-dose cisplatin for squamous cell carcinoma of the maxillary sinus.
    Kaneko T; Tada Y; Maruya S; Takeishi E; Miura K; Masubuchi T; Fushimi C; Hasegawa H; Kamata S
    Int J Oral Maxillofac Surg; 2015 Jun; 44(6):697-704. PubMed ID: 25843537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoradiotherapy for maxillary sinus adenoid cystic carcinoma using superselective intra-arterial infusion via a superficial temporal artery.
    Adachi M; Mitsudo K; Yamamoto N; Hagiwara S; Shigetomi T; Fujimoto Y; Lai SY; Tohnai I
    Head Neck; 2013 Mar; 35(3):E89-93. PubMed ID: 21953943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of late neck recurrence in N0 maxillary sinus squamous cell carcinomas after superselective intra-arterial chemoradiotherapy without prophylactic neck irradiation.
    Sakashita T; Homma A; Hatakeyama H; Kano S; Mizumachi T; Furusawa J; Yoshida D; Fujima N; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
    Eur Arch Otorhinolaryngol; 2014 Oct; 271(10):2767-70. PubMed ID: 24213278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and treatment outcomes of advanced maxillary gingival squamous cell carcinoma treated by intra-arterial infusion chemotherapy concurrent with radiotherapy.
    Hayashi Y; Osawa K; Nakakaji R; Minamiyama S; Ohashi N; Ohya T; Iida M; Iwai T; Ozawa T; Oguri S; Koizumi T; Hirota M; Kioi M; Hata M; Mitsudo K
    Head Neck; 2019 Jun; 41(6):1777-1784. PubMed ID: 30694002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton Beam Therapy in Combination with Intra-Arterial Infusion Chemotherapy for T4 Squamous Cell Carcinoma of the Maxillary Gingiva.
    Endo H; Takayama K; Mitsudo K; Nakamura T; Seto I; Yamaguchi H; Ono T; Suzuki M; Azami Y; Wada H; Murakami M; Tohnai I
    Cancers (Basel); 2018 Sep; 10(9):. PubMed ID: 30223580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligation of the ethmoid arteries in superselective intra-arterial infusion of cisplatin for advanced maxillary sinus cancer fed by the ophthalmic artery.
    Tamagawa K; Shinomiya H; Okada T; Tatehara S; Teshima M; Sasaki R; Nibu KI
    Head Neck; 2023 May; 45(5):E16-E24. PubMed ID: 36891662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (Japan Clinical Oncology Group 1212): Dose-finding phase.
    Homma A; Onimaru R; Matsuura K; Shinomiya H; Sakashita T; Shiga K; Tachibana H; Nakamura K; Mizusawa J; Kitahara H; Eba J; Fukuda H; Fujii M; Hayashi R
    Head Neck; 2018 Mar; 40(3):475-484. PubMed ID: 29130565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment results of alternating chemoradiotherapy followed by proton beam therapy boost combined with intra-arterial infusion chemotherapy for stage III-IVB tongue cancer.
    Takayama K; Nakamura T; Takada A; Makita C; Suzuki M; Azami Y; Kato T; Hayashi Y; Ono T; Toyomasu Y; Hareyama M; Kikuchi Y; Daimon T; Mitsudo K; Tohnai I; Fuwa N
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):659-67. PubMed ID: 26521257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer.
    Homma A; Sakashita T; Yoshida D; Onimaru R; Tsuchiya K; Suzuki F; Yasuda K; Hatakeyama H; Furusawa J; Mizumachi T; Kano S; Inamura N; Taki S; Shirato H; Fukuda S
    Br J Cancer; 2013 Dec; 109(12):2980-6. PubMed ID: 24196792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer: analysis of therapeutic results in 112 cases.
    Mitsudo K; Koizumi T; Iida M; Iwai T; Nakashima H; Oguri S; Kioi M; Hirota M; Koike I; Hata M; Tohnai I
    Radiother Oncol; 2014 May; 111(2):306-10. PubMed ID: 24746571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.
    Hamauchi S; Yokota T; Onozawa Y; Ogawa H; Onoe T; Kamijo T; Iida Y; Nishimura T; Onitsuka T; Yasui H
    Jpn J Clin Oncol; 2015 Dec; 45(12):1116-21. PubMed ID: 26423341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.